GLI4
Basic information
Region (hg38): 8:143267433-143276931
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLI4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 51 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 1 | 0 |
Variants in GLI4
This is a list of pathogenic ClinVar variants found in the GLI4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-143269401-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
8-143269417-T-G | not specified | Uncertain significance (Dec 05, 2024) | ||
8-143269483-C-G | not specified | Uncertain significance (Oct 04, 2022) | ||
8-143269486-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
8-143274766-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
8-143274781-G-A | not specified | Uncertain significance (Jan 31, 2025) | ||
8-143275911-C-G | not specified | Uncertain significance (Feb 06, 2024) | ||
8-143275915-A-C | not specified | Uncertain significance (Jan 23, 2024) | ||
8-143275917-C-A | not specified | Uncertain significance (Feb 04, 2025) | ||
8-143275927-G-T | not specified | Uncertain significance (Oct 16, 2024) | ||
8-143275930-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
8-143275935-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
8-143275948-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
8-143275965-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
8-143275980-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
8-143275998-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
8-143275999-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
8-143275999-G-T | not specified | Uncertain significance (Dec 28, 2023) | ||
8-143276001-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
8-143276053-C-T | not specified | Uncertain significance (Oct 11, 2024) | ||
8-143276073-G-A | not specified | Uncertain significance (Jan 25, 2023) | ||
8-143276080-G-T | not specified | Uncertain significance (Sep 24, 2024) | ||
8-143276115-G-A | not specified | Uncertain significance (Oct 08, 2024) | ||
8-143276128-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
8-143276136-C-A | not specified | Likely benign (May 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GLI4 | protein_coding | protein_coding | ENST00000340042 | 3 | 9499 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00237 | 0.933 | 125649 | 0 | 19 | 125668 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.679 | 238 | 210 | 1.13 | 0.0000126 | 2397 |
Missense in Polyphen | 115 | 96.482 | 1.1919 | 1011 | ||
Synonymous | -1.02 | 112 | 99.1 | 1.13 | 0.00000675 | 763 |
Loss of Function | 1.61 | 6 | 12.0 | 0.499 | 5.20e-7 | 128 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000583 | 0.0000583 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000624 | 0.0000616 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000328 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Tumor suppressor activity of SMARCB1
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;biological_process
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;molecular_function;DNA binding;DNA-binding transcription factor activity;metal ion binding